Entecavir add-on Peg-interferon therapy plays a positive role in reversing hepatic fibrosis in treatment-na(i)ve chronic hepatitis B patients: a prospective and randomized controlled trial

著录项

• 来源
  《中华医学杂志（英文版）》 |2020年第14期|1639-1648|共10页
• 作者

  Jing-Mao Yang; Xiao Ming; Xian Li; Shao-Ping Huang; Ji-Lin Cheng; Li-Ping Chen; Ya-Jie Wang; Bei Lyu; Hong Zhao; Zhi-Yin Shang; Jun Li; Zhen-Yu Fan; Sheng-Di Wu;

  展开▼
• 作者单位

  Department of Gastroenterology and Hepatology Shanghai Public Health Clinical Center Fudan University Shanghai 201500 China;

  Department of Gastroenterology and Hepatology Shanghai Public Health Clinical Center Fudan University Shanghai 201500 China;

  Department of Gastroenterology and Hepatology Shanghai Public Health Clinical Center Fudan University Shanghai 201500 China;

  Department of Gastroenterology and Hepatology Shanghai Public Health Clinical Center Fudan University Shanghai 201500 China;

  Department of Gastroenterology and Hepatology Shanghai Public Health Clinical Center Fudan University Shanghai 201500 China;

  Shanghai Medical College of Fudan University Shanghai 200032 China;

  Department of Gastroenterology and Hepatology Jinshan Hospital Fudan University Shanghai 201500 China;

  Department of Gastroenterology and Hepatology Zhongshan Hospital Fudan University Shanghai 200032 China;

  Department of Gastroenterology and Hepatology Dongyang People's Hospital Dongyang Zhejiang 322100 China;

  Department of Gastroenterology and Hepatology Shanghai Public Health Clinical Center Fudan University Shanghai 201500 China;

  Department of Gastroenterology and Hepatology Shanghai Public Health Clinical Center Fudan University Shanghai 201500 China;

  Department of Gastroenterology and Hepatology Shanghai Public Health Clinical Center Fudan University Shanghai 201500 China;

  Department of Gastroenterology and Hepatology Zhongshan Hospital Fudan University Shanghai 200032 China;

  展开▼
• 收录信息 中国科学引文数据库(CSCD);
• 原文格式 PDF
• 正文语种 eng
• 中图分类
• 关键词